MedTrace Logo

Hemodynamic Stability of Dexmedetomidine in Hypertensive Patients Undergoing Laparoscopic Cholecystectomy

NCT04646317 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-12-22

No results posted yet for this study

Summary

Dexmedetomidine provides better hemodynamic stability to the patients with hypertension undergoing laparoscopic cholecystectomy.

Conditions

Interventions

DRUG

Dexmedetomidine injection

Infusion of dexmedetomidine will be prepared in Four syringes of 50ml containing dexmedetomidine in concentration of 1 microgram per millilitre.

DRUG

Normal Saline

0.9% as placebo

Sponsors & Collaborators

  • Dr. Ruth K.M. Pfau Civil Hospital, Karachi

    lead OTHER_GOV

Principal Investigators

  • Muhammad Imran, FCPS · Dow University of Health Sciences

  • Hanya Javaid, FCPS · Dow University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2021-03-02
Completion
2021-03-02

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04646317 on ClinicalTrials.gov